Xanthohumol reduced ABCG2 protein levels in doxorubicin-resistant breast cancer cells [89], while CYP-2B had no effect in NCI-H460/MX20 lung carcinoma cells [69]. The gene discussed is ABCG2; the disease is breast carcinoma.